Drug profile

The FDA adverse-event record for Insulin Pork

47 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Insulin Pork. See the species affected, top reactions, and outcomes below.

47
adverse-event reports
4.3%
death-coded share
Dog
most-reported species
31
INEFFECTIVE, GLYCEMIC CONTROL - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
47
Total Reports
2
Deaths Reported
4.3%
Death Rate

Active Ingredients

Insulin Pork

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 37
Cat 8
Human 1
Unknown 1

Most Affected Breeds

Crossbred Canine/dog 7
Crossbred Feline/cat 5
Retriever - Labrador 4
Chihuahua 3
Terrier - Jack Russell 3
Schnauzer (unspecified) 3
Dog (unknown) 3
Pug 2
Unknown 2
Spaniel - Springer (unspecified) 2

Most Reported Reactions

INEFFECTIVE, GLYCEMIC CONTROL 31
INEFFECTIVE, LOSS OF EFFECT 9
Drug preparation error 6
Hypoglycaemia 5
Lethargy (see also Central nervous system depression in Neurological) 4
Lack of efficacy - NOS 4
Vocalisation 3
Weight loss 3
Vomiting 3
Injection site pain 2
Decreased appetite 2
Drug dose administration interval too short 2

Outcome Breakdown

Ongoing
19 (41.3%)
Outcome Unknown
17 (37.0%)
Recovered/Normal
8 (17.4%)
Euthanized
2 (4.3%)

Insulin Pork Adverse Event Insights

47 reports name Insulin Pork; 2 recorded a death outcome (4.3% of reported events, not a population-level mortality rate). Active ingredient: Insulin Pork. Administration routes: Subcutaneous, Unknown.

By species: Dog (37 reports), Cat (8 reports), Human (1 reports). By breed: Crossbred Canine/dog (7), Crossbred Feline/cat (5), Retriever - Labrador (4).

Leading clinical signs: INEFFECTIVE, GLYCEMIC CONTROL (31), INEFFECTIVE, LOSS OF EFFECT (9), Drug preparation error (6), Hypoglycaemia (5). Outcome, 46 coded reports: Ongoing leads at 41.3%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.